Delivery Order SPE2DB24D2100-SPE2DB25FBBZF

Award Date 1/31/25
Potential Completion Date 2/24/25
Potential Value $8.1K
Ultimate Awardee
Not listed
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract has a total ceiling value of $8,067.35 and runs through February 6, 2025. It is a firm fixed-price contract for the delivery of IBRANCE 75 MG CAPSULE 21S, a pharmaceutical product. The contract is not designated as a set-aside. AmerisourceBergen holds a larger Indefinite Delivery Contract (IDC) with...
This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $8,067.35, is for the delivery of IBRANCE 75 MG CAPSULE 21S, a pharmaceutical product. The contract has a period of performance through March 21, 2025 and is a firm fixed-price contract. The contract is not set aside for any specific socioeconomic program. AmerisourceBergen holds a...
This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract has a ceiling value of $7,796.30 and is for the delivery of IBRANCE 100 MG CAPSULE 21S, a pharmaceutical product. The contract has an ultimate completion date of February 28, 2024 and is a firm fixed-price delivery order. It is not designated as a set-aside contract. AmerisourceBergen Drug Corp holds a...
This is a federal contract award to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider, by the Defense Logistics Agency (DLA). The contract is a Delivery Order with a Firm Fixed Price pricing type, valued at $8,067.35, and has an ultimate completion date of January 17, 2025. The contract covers the supply of IBRANCE 75 MG CAPSULE 21S, a pharmaceutical product, to support federal healthcare programs. Amerisourcebergen holds a significant Indefinite...
This is a Delivery Order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract has a ceiling value of $8,061.38 and covers the delivery of IBRANCE 125 MG CAPSULE 21S, a prescription medication, through March 3, 2025. The contract is a Firm Fixed Price Delivery Order, with no set-aside designation, indicating open competition. AmerisourceBergen holds a significant Indefinite...
This federal contract award is a delivery order valued at $8,123.96 issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the supply of IBRANCE 75 MG CAPSULE 21S, a pharmaceutical product, and has an ultimate completion date of April 11, 2025. The contract is an Indefinite Delivery Contract (IDC) between AmerisourceBergen and the DLA Troop Support Medical, with a ceiling value of...
This is a delivery order issued to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, by the Defense Logistics Agency (DLA) Troop Support Medical. The contract is for the supply of IBRANCE 75 MG CAPSULE 21S, a pharmaceutical product, and has a ceiling value of $8,067.35. The contract is a firm-fixed price delivery order with a period of performance through January 22, 2025. Amerisourcebergen holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support...
This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of IBRANCE 100 MG TABLET 7S, a pharmaceutical product. The contract has a ceiling value of $8,065.75 and is a firm fixed price contract. The ultimate completion date is January 21, 2025. This contract is part of a larger Indefinite Delivery Contract (IDC) that AmerisourceBergen...
This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, for the provision of the drug IBRANCE 125 MG CAPSULE 21S. The contract has a ceiling value of $8,061.38 and runs through January 17, 2025. It is a firm fixed-price contract with no set-aside designation, indicating open competition. Amerisourcebergen holds a larger Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued at...
This is a federal delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $8,067.35, is for the supply of IBRANCE 75 MG CAPSULE 21S, a prescription medication. The contract has a firm fixed price and an ultimate completion date of February 11, 2025. AmerisourceBergen holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical,...
  • SPE2DB24D2100
    Indefinite Delivery Contract
  • SPE2DB24D2100-SPE2DB25FBBZF
    Delivery Order

This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract has a ceiling value of $8,067.35 and a completion date of February 24, 2025. It is a firm fixed-price contract for the delivery of IBRANCE 75 MG CAPSULE 21S, a pharmaceutical product.

The contract is not designated as a set-aside. AmerisourceBergen holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued at $999,999,999 and running through November 2026. This IDC serves as a primary vehicle for providing a comprehensive range of pharmaceutical products and medical supplies to support military healthcare programs globally. AmerisourceBergen also maintains a separate IDC with the Department of Justice Federal Bureau of Investigation, valued at $750,000 through May 2024, which covers similar medical products and prescription drugs.

Generated 5/2/25, 9:46 AM